Portugal
Ipca Laboratories Ltd (BOM:524494) Q1 2025 Earnings Call Transcript Highlights: Strong Domestic Growth Amid Export Challenges
Domestic Formulation Growth: 12% for Q1 FY25.Market Share: Increased to 2.17% in Q1 FY25 from 2.06% in Q1 FY24.Export Formulation Business: Declined by 1% from